DALLAS, April 22, 2026 - Scientific research teams from Mass General Brigham Heart and Vascular Institute in Boston, Cincinnati Children's Hospital Center and the University of Pittsburgh will lead a new $15 million initiative dedicated to better understanding how to diagnose and treat heart valve disease . The Strategically Focused Research Network on Earlier Detection and Delaying Progression of Valvular Heart Disease is the latest research network funded by the American Heart Association, a global force changing the future of health for all.
According to the American Heart Association's 2026 Heart Disease and Stroke Statistics , more than 80 million people worldwide are living with some type of heart valve disease, and the numbers are climbing. In the U.S., the condition contributes to more than 57,000 deaths each year.
Heart valve disease is a common cardiovascular condition in which one or more of the heart's four valves are narrowed and restrict blood flow or do not close properly which causes blood to flow backward rather than into the heart chambers or large blood vessels.
AHA News (American Heart Association) published a clinical update in Cardiology on 22 Apr 2026.
The item focuses on Scientific researchers awarded $15 million to study heart valve disease.
Review the original article for the full source wording and details.